Stock Research: Almirall

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Almirall

BME:ALM ES0157097017
96
  • Value
    58
  • Growth
    97
  • Safety
    Safety
    65
  • Combined
    94
  • Sentiment
    87
  • 360° View
    360° View
    96
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Almirall SA is a pharmaceutical company focused on developing and marketing drugs for various therapeutic areas. The company operates in pharmaceuticals, including nervous system, gastrointestinal, dermatological, respiratory system, and antiinfectives. It operates in Europe, the Americas, Africa, Asia, and Australia. In the last fiscal year, the company had a market cap of $2,641 million, profits of $795 million, and revenue of $1,021 million with 2026 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 96 (better than 96% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Almirall are very positive. The 360° View is based on consolidating four consolidated indicators, with all four indicators above average for Almirall. The consolidated Value Rank has an attractive rank of 65, which means that the share price of Almirall is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 65% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 97, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The company is also safely financed with a Safety rank of 58. Finally, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 87. ...read more

more
Index
IBEX 35
Sound Pay Europe
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
65 72 67 72
Growth
97 24 27 41
Safety
Safety
58 56 68 70
Sentiment
87 65 54 54
360° View
360° View
96 54 59 72
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
76 78 53 69
Opinions Change
66 26 63 50
Pro Holdings
n/a 46 24 22
Market Pulse
61 83 71 65
Sentiment
87 65 54 54
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
65 72 67 72
Growth
97 24 27 41
Safety Safety
58 56 68 70
Combined
94 61 60 63
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
34 32 22 37
Price vs. Earnings (P/E)
66 67 69 83
Price vs. Book (P/B)
65 80 88 83
Dividend Yield
54 51 55 57
Value
65 72 67 72
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
79 83 56 37
Profit Growth
100 10 33 39
Capital Growth
64 4 16 71
Stock Returns
81 53 46 42
Growth
97 24 27 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
62 63 56 45
Refinancing
69 67 79 80
Liquidity
32 35 36 41
Safety Safety
58 56 68 70

Similar Stocks

Discover high‑ranked alternatives to Almirall and broaden your portfolio horizons.

Perrigo

NYSE:PRGO
Country: Ireland
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Continental

XTRA:CON
Country: Germany
Industry: Auto Parts & Equipment
Size: X-Large
Full Stock Analysis

Polski Koncern Naftowy ORLEN Spolka Akcyjna

WSE:PKN
Country: Poland
Industry: Oil & Gas Refining
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.